Acrux (ASX:ACR) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 07, 2026)


What is Acrux 5-Year Yield-on-Cost %?

Acrux ASX:ACR -4.17% 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. The stock has 6 warning signs investors should review. Among 152 Biotechnology companies, Acrux ranks worse than 657894.08% on this metric.

Acrux's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Acrux's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Acrux's highest Yield on Cost was 26.67. The lowest was 7.69. And the median was 19.05.


ASX:ACR's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.665
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Acrux  (ASX:ACR) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Acrux 5-Year Yield-on-Cost % Related Terms

ASX:ACR vs VRTX, REGN, ALNY: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Acrux's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acrux 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrux's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Acrux's 5-Year Yield-on-Cost % falls into.


Acrux 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Acrux is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Acrux (ASX:ACR) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Acrux and its competitors. Over the past decade, Acrux's 5-Year Yield-on-Cost % has ranged from 7.69 to 26.67. According to the industry distribution chart, Acrux ranks #999999 out of 152 companies in the Biotechnology industry.
Is Acrux's 5-Year Yield-on-Cost % too high?
Acrux's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 7.69 to a high of 26.67. Based on the distribution chart, Acrux ranks #999999 out of 152 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Acrux's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrux ranks #999999 out of 152 companies for 5-Year Yield-on-Cost %. This places Acrux in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.67. Historically, Acrux's own 5-Year Yield-on-Cost % has ranged from 7.69 to 26.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.67, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Acrux and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acrux's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrux stock overvalued right now?
Based on GuruFocus' analysis, Acrux (ASX:ACR) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.03, compared to a current price of A$0.01 — trading 61.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Acrux (ASX:ACR), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acrux Business Description

Other Exchanges ARUXF:USAFJY:Germany
Address 103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Acrux Ltd is a dynamic Australian drug delivery specialist with expertise in developing and commercialising patient-preferred healthcare products for world-wide markets. Its talent creates value through the development and commercialisation of healthcare products using owned or acquired technologies. The group's products are patient preferred, protected by patent or other means, and use creative drug delivery.